Leeward Investments LLC MA Sells 6,281 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB)

Leeward Investments LLC MA decreased its holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) by 7.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 82,872 shares of the semiconductor company’s stock after selling 6,281 shares during the quarter. Leeward Investments LLC MA’s holdings in Silicon Laboratories were worth $10,294,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Pacer Advisors Inc. raised its stake in Silicon Laboratories by 1.8% in the fourth quarter. Pacer Advisors Inc. now owns 4,839 shares of the semiconductor company’s stock valued at $601,000 after buying an additional 87 shares during the period. Louisiana State Employees Retirement System raised its stake in Silicon Laboratories by 1.1% in the fourth quarter. Louisiana State Employees Retirement System now owns 9,000 shares of the semiconductor company’s stock valued at $1,118,000 after buying an additional 100 shares during the period. Procyon Advisors LLC raised its stake in Silicon Laboratories by 4.4% in the fourth quarter. Procyon Advisors LLC now owns 3,176 shares of the semiconductor company’s stock valued at $395,000 after buying an additional 133 shares during the period. Truist Financial Corp increased its stake in shares of Silicon Laboratories by 0.7% during the fourth quarter. Truist Financial Corp now owns 21,699 shares of the semiconductor company’s stock worth $2,695,000 after purchasing an additional 151 shares during the period. Finally, Advisors Asset Management Inc. increased its stake in shares of Silicon Laboratories by 159.4% during the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock worth $32,000 after purchasing an additional 169 shares during the period.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on SLAB shares. Morgan Stanley lowered their target price on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Needham & Company LLC increased their target price on Silicon Laboratories from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. lowered their target price on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 5th. Stifel Nicolaus increased their target price on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Monday, January 6th. Finally, Barclays increased their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $136.20.

Insider Buying and Selling at Silicon Laboratories

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the firm’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the sale, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. This trade represents a 5.86 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm’s stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the completion of the sale, the director now directly owns 400,567 shares in the company, valued at approximately $59,684,483. This represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,360 shares of company stock valued at $782,610. 1.72% of the stock is currently owned by corporate insiders.

Silicon Laboratories Price Performance

Silicon Laboratories stock opened at $155.33 on Friday. The stock’s fifty day moving average price is $136.14 and its two-hundred day moving average price is $119.89. Silicon Laboratories Inc. has a one year low of $94.00 and a one year high of $160.00. The firm has a market cap of $5.04 billion, a PE ratio of -26.15 and a beta of 1.16.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. During the same quarter last year, the company earned ($1.19) EPS. The company’s revenue was up 91.4% on a year-over-year basis. Sell-side analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.